Patients with migraine and headache disorders who also have photophobia may have greater interictal light sensitivity compared with those without photophobia and healthy individuals.
Investigators analyzed the efficacy and safety of intravenous metoclopramide to treat acute migraine headaches.
Flunarizine may be safe, effective, and well-tolerated as a prophylactic treatment for episodic migraine.
Allergan announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application for ubrogepant, a highly potent oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine in adults.
Three physical examination tests may be useful in confirming the presence of cervical musculoskeletal impairments in patients with migraine.
Researchers found that visual stimulus in the high frequency range caused abnormal neurological responses in women who had migraines.
Through the use of MRIs, by T2 mapping, myofascial trigger points are identified and quantified, which the researchers believe show targets for interventions.
Investigators found that bilateral surgery showed the greatest improvement with more migraine-free days postsurgery.
The study underscores the importance of migraine with aura symptom onset in the evaluation of ischemic stroke risk in late life.
Researchers studied women who had migraines compared with healthy controls (using MRI images at the lobar level) finding no correlation between cortical thickness and migraines.